1. MO532: Cardiovascular Events in Patients With Non–Dialysis-Dependent Chronic Kidney Disease and Anemia: Regional Analysis of Patients Previously Treated With Erythropoiesis-Stimulating Agents in the PRO2TECT Trial. (3rd May 2022) Authors: Parfrey, Patrick; Chertow, Glenn; Eckardt, Kai-Uwe; Burke, Steven; Luo, Wenli; Minga, Todd; Winkelmayer, Wolfgang Journal: Nephrology dialysis transplantation Issue: Volume 37(2022)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MO536: Cardiovascular Events in Patients With Anemia Associated With Non–Dialysis-Dependent Chronic Kidney Disease: Regional Analysis of Patients not Previously Treated With Erythropoiesis-Stimulating Agents in The PRO2TECT Trial. (3rd May 2022) Authors: Winkelmayer, Wolfgang; Arnold, Susan; Burke, Steven; Chertow, Glenn; Eckardt, Kai-Uwe; Luo, Wenli; Minga, Todd; Parfrey, Patrick Journal: Nephrology dialysis transplantation Issue: Volume 37(2022)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SP581VONAPANITASE PIVOTAL TRIAL TO INCREASES FISTULA USE FOR HEMODIALYSIS AND SECONDARY PATENCY. (13th June 2019) Authors: Bleyer, Anthony; Lee, Timmy; Burke, Steven Journal: Nephrology dialysis transplantation Issue: Volume 34(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗